Voltarol Emulgel P 1% w/w Gel

  • Name:

    Voltarol Emulgel P 1% w/w Gel

  • Company:
    info
  • Active Ingredients:

    Diclofenac diethylammonium

  • Legal Category:

    Supply through pharmacy only

Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 25/03/19

files-icon(Click to Download)
Summary of Product Characteristics last updated on medicines.ie: 12/3/2019

Click on this link to Download PDF directly

GlaxoSmithKline Consumer Healthcare (Ireland) Ltd

GlaxoSmithKline Consumer Healthcare (Ireland) Ltd

Company Products

Medicine NameActive Ingredients
Medicine Name Andrews Liver Salts Effervescent Powder Active Ingredients Citric Acid (Anhydrous), Magnesium sulfate (dihydrate), Sodium Hydrogen Carbonate
Medicine Name Corsodyl Aniseed 0.2% w/v Mouthwash Active Ingredients Chlorhexidine digluconate
Medicine Name Corsodyl 1% w/w Dental Gel Active Ingredients Chlorhexidine digluconate
Medicine Name Corsodyl Mint 0.2% w/v Mouthwash Active Ingredients Chlorhexidine digluconate
Medicine Name Day Nurse Capsules Active Ingredients Paracetamol, Pholcodine, Pseudoephedrine Hydrochloride
Medicine Name Duofilm Cutaneous Solution Active Ingredients Lactic Acid, Salicylic Acid
Medicine Name Eurax 10% w/w Cream Active Ingredients Crotamiton
Medicine Name Excedrin 250 mg /250 mg /65 mg film-coated tablets Active Ingredients Aspirin, Caffeine, Paracetamol
Medicine Name Flixonase Allergy Relief Nasal Spray Active Ingredients Fluticasone Propionate
Medicine Name Lamisil 1% w/w Cream Active Ingredients Terbinafine hydrochloride
Medicine Name Lamisil AT Cream Active Ingredients Terbinafine hydrochloride
Medicine Name Lamisil Once 1% cutaneous solution Active Ingredients Terbinafine hydrochloride
Medicine Name Nicotinell Cool Mint 2mg medicated chewing gum Active Ingredients Nicotine-polacrilin
Medicine Name Nicotinell Cool Mint 4mg medicated chewing gum Active Ingredients Nicotine-polacrilin
Medicine Name Nicotinell Fruit 2mg medicated chewing-gums Active Ingredients Nicotine-polacrilin
Medicine Name Nicotinell Fruit 4mg Medicated Chewing-Gums Active Ingredients Nicotine-polacrilin
Medicine Name Nicotinell Mint 1mg Compressed Lozenges Active Ingredients nicotine bitartrate dihydrate
Medicine Name Nicotinell Mint 2mg compressed Lozenges Active Ingredients nicotine bitartrate dihydrate
Medicine Name Nicotinell TTS 10, 7 mg/24 hour Transdermal Patch Active Ingredients Nicotine
Medicine Name Nicotinell TTS 20, 14 mg/24 hour Transdermal Patch Active Ingredients Nicotine
Medicine Name Nicotinell TTS 30, 21 mg/24 hour Transdermal Patch Active Ingredients Nicotine
Medicine Name Night Nurse Capsules Active Ingredients Dextromethorphan Hydrobromide, Paracetamol, Promethazine hydrochloride
Medicine Name Night Nurse Cold Remedy Active Ingredients Dextromethorphan Hydrobromide, Paracetamol, Promethazine hydrochloride
Medicine Name Oilatum Cream Active Ingredients Light Liquid Paraffin, White Soft Paraffin
Medicine Name Oilatum Emollient 63.4% w/w Bath Additive Active Ingredients Light Liquid Paraffin
1 - 0 of 52 items.Total: Infinity pages

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 25 March 2019 PIL

Reasons for updating

  • Change to section 6 - manufacturer

Updated on 12 March 2019 PIL

Reasons for updating

  • Change to section 6 - what the product looks like and pack contents

Updated on 12 March 2019 SmPC

Reasons for updating

  • Change to section 6.5 - Nature and contents of container

Legal category: Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

Additional of the no mess cap for the 100 g pack.

Updated on 12 March 2019 SmPC

Reasons for updating

  • Change to section 6.5 - Nature and contents of container

Legal category: Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

Change to add an additional cap on the 100g pack size to allow for consumers to apply the product without using their hands to rub it in.

Updated on 27 October 2016 PIL

Reasons for updating

  • New PIL for new product

Updated on 27 October 2016 PIL

Reasons for updating

  • Change to section 6 - marketing authorisation holder
  • Change to section 6 - marketing authorisation number

Updated on 3 October 2016 SmPC

Reasons for updating

  • New SmPC for new product

Legal category: Supply through pharmacy only

Updated on 3 October 2016 SmPC

Reasons for updating

  • Change to section 7 - Marketing authorisation holder
  • Change to section 8 - MA number
  • Change to section 10 - Date of revision of the text

Legal category: Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

Sections 7, 8 & 10 updated following Change of Ownership approval

Updated on 3 May 2016 PIL

Reasons for updating

  • New PIL for medicines.ie

Updated on 8 December 2014 SmPC

Reasons for updating

  • Change to Section 4.8 – Undesirable effects - how to report a side effect
  • Change to section 6.5 - Nature and contents of container

Legal category: Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

In section: 4.8 Undesirable effects

 

The following has been added.

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via HPRA Pharmacovigilance, Earlsfort Terrace, IRL - Dublin 2; Tel: +353 1 6764971; Fax: +353 1 6762517. Website: www.hpra.ie; E-mail: medsafety@hpra.ie.

 

 



In section: 6.5       Nature and contents of container

Pack sizes has been added,
 50g & 100g.

Updated on 15 October 2014 SmPC

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 7 - Marketing authorisation holder
  • Change to section 10 - Date of revision of the text

Legal category: Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

Section 4.4

“It should not be used with occlusion” added

Paragraph concerning excipients – slightly reworded

 

Section 7

Address changed to Camberley

 

 

Section 10

Date changed from Sept 2013 to August 2014

Updated on 16 September 2013 SmPC

Reasons for updating

  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 4.3 - Contraindications
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 5.1 - Pharmacodynamic properties
  • Change to section 5.2 - Pharmacokinetic properties
  • Change to section 5.3 - Preclinical safety data
  • Change to section 6.1 - List of excipients
  • Change to section 10 - Date of revision of the text

Legal category: Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

Section 2

 

Addition of benzyl benzoate to excipients list

 

Section 4.3

 

“isopropranol” changed to “isopropyl alcohol”

 

“Acetylsalicylic acid” changed to “aspirin”

 

Section 4.4

 

Under “Information concerning excipients” information added regarding irritant effect of benzyl benzoate.

 

Section 5.1

 

Section rewritten to include more information about mode of action and clinical data

 

Section 5.2

 

Section rewritten and split into subsections to include more information on absorption, distribution, biotransformation, elimination and activity in patients.

 

Section 5.3

 

Additional information added regarding preclinical experience with product.

 

Section 6.1

 

Addition of “(including benzyl benzoate)” after perfume.

 

Section 10

 

Date of revision changed from 16 November 2012 to 10 September 2013.

Updated on 20 December 2012 SmPC

Reasons for updating

  • Change to section 4.3 - Contraindications
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.6 - Pregnancy and lactation
  • Change to section 4.7 - Effects on ability to drive and use machines
  • Change to section 4.8 - Undesirable effects
  • Change to section 4.9 - Overdose

Legal category: Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

Section 4.3 

Add contraindications for last trimester of pregnancy and replace general statement about hypersensitivity to gel ingredients with specific statement referring to propylene glycol and isopropanol.

 

Section 4.4  

Add “The possibility of systemic adverse events from application of Voltarol Emulgel P cannot be excluded if the preparation is used on large areas of skin and over a prolonged period (see the product information on systemic forms of diclofenac).”

Discontinue the treatment if a skin rash develops after applying the product.

 

Voltarol Emulgel P can be used with non-occlusive bandages but should not be used with an airtight occlusive dressing.”


and “Voltarol Emulgel P contains propylene glycol, which may cause mild localised skin irritation in some people.”

 

Delete “It should not be used with occlusion”.  Replace “never be taken by mouth” with “not be ingested”

 

Section 4.5

Reword opening paragraph to “Since systemic absorption of diclofenac from topical application is very low, such interactions are very unlikely.”

 

Section 4.6
 

Change heading to “Fertility, pregnancy and lactation”
 

Previous information replaced with data to clarify recommendations associated with use in pregnancy and lactation, including contraindication in third trimester.


Section 4.7

 

Replace previous text with “Cutaneous application of Topical diclofenac has no influence on the ability to drive and use machines.”

 


Section 4.8

 

Frequencies for side effects have been added as per convention as well as table of reactions. 

 

Section 4.9
 

Add “However, undesirable effects, similar to those observed following an overdose of diclofenac tablets, can be expected if Voltarol Emulgel P is inadvertently ingested (1 tube of 100g contains the equivalent of 1000mg of diclofenac sodium).”

 

Add “Gastric decontamination and the use of activated charcoal should be considered, especially within a short time of ingestion.”

 

Updated on 20 October 2011 SmPC

Reasons for updating

  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.3 - Contraindications
  • Change to section 9 - Date of renewal of authorisation
  • Change to section 10 - Date of revision of the text

Legal category: Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

Section 4.2

Deletion of paragraph: Children: Not recommended

Addition of paragraph:  Children and adolescents below 14 years: There are insufficient data on efficacy and safety available for children and adolescents below 14 years of age (see also contraindications section 4.3). In children aged 14 years and over, if this product is required for more than 7 days for pain relief or if the symptoms worsen the patient/parents of the adolescent is/are advised to consult a doctor.

 

 

Section 4.3

Addition of paragraph: The use in children and adolescents aged less than 14 years is contraindicated.

 

 

Section 9

Date of last renewal changed from 31 October 2008 to 17 October 2008.

 

 

Section 10

Date changed from October 2010 to October 2011

Updated on 11 January 2011 SmPC

Reasons for updating

  • Change to product name
  • Change to section 1 - Name of medicinal product
  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.7 - Effects on ability to drive and use machines
  • Change to section 5.3 - Preclinical safety data
  • Change to section 6.4 - Special precautions for storage
  • Change to section 6.5 - Nature and contents of container
  • Change to section 9 - Date of renewal of authorisation
  • Change to section 10 - Date of revision of the text

Legal category: Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

Product name changed from Voltarol Emulgel P to Voltarol Emulgel P 1% w/w Gel.

Section 1

Addition of ‘1% w/w Gel’.

 

Section 2

Addition of  ‘Contains propylene glycol 5% w/w’. For full list of excipients see Section 6.1.

 

Section 4.2

New title added ‘Topical application’.

 

Section 4.5

Paragraph 1

The words ‘To date’ added at beginning of the paragraph.

 

Paragraph 2

The word ‘concentrations’ has been changed to ‘levels’.

 

Section 4.7

Paragraph: ‘Those who experience dizziness or other central nervous sytem disturbances, including visual disturbances, while taking NSAIDs should refrain from driving or operating machinery’ replaces ‘See side effects’.

 

Section 5.3

Addition of ‘Preclinical studies conducted with Voltarol Emulgel did not reveal any clinical relevant toxicological effects’ replaces ‘None known’.

 

Section 6.4

Wording changed from ‘Store below 30’ to ‘Do not store above 30’.

 

Section 6.5

Addition of words ‘available in packs of 10g and 30g’ at end of first paragraph.

Addition of words ‘available in packs of 30g’ at end of second paragraph.

Deletion of words ‘Both available in packs of 10g and 30g’.

 

Section 9

‘Date of first authorisation : 17 October 2003.  Date of last renewal: 31 October 2008’ replaces’ 17 October 2003’.

 

Section 10

Date change from 29 September 2008 to October 2010.

Updated on 26 February 2009 SmPC

Reasons for updating

  • Change to section 6.5 - Nature and contents of container
  • Change to section 6.6 - Special precautions for disposal and other handling
  • Change to section 10 - Date of revision of the text

Legal category: Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

Voltarol Emulgel P ROI- changes to SPC September 2008

 

Section 6.5: addition of description of colour of polypropylene screw cap white or blue

Section 6.6: change in section heading name from Instructions for Use/Handling to Special precautions for disposal

 

Section 10: revision date change from Aug 2007 to September 2008

 

Updated on 16 July 2008 SmPC

Reasons for updating

  • Change to section 6.5 - Nature and contents of container
  • Change to section 9 - Date of renewal of authorisation
  • Change to section 10 - Date of revision of the text

Legal category: Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

Section 6.5: Further information added regarding the aluminium laminated tubes Section 9: Date of last renewal added

Section 10: Revision date changed

Updated on 10 August 2005 SmPC

Reasons for updating

  • New SPC for new product

Legal category: Supply through pharmacy only